Keros TherapeuticsÂ Inc (KROS) Financials

$11.31

$0.14 (1.25%)

As on 09-Sep-2026 16:00EDT

Market cap

$224 Mln

Revenue (TTM)

$33 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	33.18	244.06	3.55	0.15	20.00	20.10
Cost of Revenue	1.20	1.51	1.23	0.82	1.62	0.90
Gross Profit	14.22	242.55	3.55	0.15	-1.62	20.10
Operating Expenses	115.68	171.93	214.38	170.09	114.79	76.47
Operating Profit (EBIT)	-101.47	70.62	-210.83	-169.94	-114.79	-56.37
Other Income	--	--	--	--	10.11	-0.36
Profit before Tax	-86.10	91.90	-187.05	-152.99	-104.68	-56.73
Provision for Tax	-0.72	4.88	0.30	-0.21	0.00	2.01
Profit after Tax (Net Income)	-83.16	87.01	-187.35	-152.99	-104.68	-58.74
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-104.68	-58.74

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	262.32	303.13	571.55	332.21	277.42	243.17
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	13.13	14.48	16.88	13.44	12.81	0.23
Current Liabilities	12.15	20.41	27.45	24.37	16.55	11.85
Total Liabilities	299.75	338.02	615.89	370.03	306.78	255.25

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	20.72	22.59	26.99	22.73	21.01	3.81
Current Assets	266.88	315.43	588.89	347.29	285.77	251.44
Total Assets	299.75	338.02	615.89	370.03	306.78	255.25
Total Debt*	15.72	16.88	18.86	14.44	13.27	1.09
Net Current Assets	254.73	295.02	561.44	322.92	269.22	239.59

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	107.51	-160.87	-124.51	-70.06	-62.15
Cash Flow from Investing Activities	--	-1.55	-1.93	-2.46	-1.24	-1.02
Cash from Financing Activities	--	-378.47	391.82	178.96	120.31	28.55
Net Cash Inflow / Outflow	--	--	--	--	49.01	-34.62

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-3.70	3.20	-4.64	-5.08	-3.83	-2.51
Cash EPS ($)	--	3.25	-4.61	-5.05	-3.81	-2.49
Adjusted Book Value ($)	--	11.15	14.17	11.03	10.15	10.38
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	3.95	-3.99	-4.13	-2.56	-2.65
Free Cash Flow per Share ($)	--	3.90	-4.04	-4.21	-2.61	-2.70

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	19.11	-39.99	-48.01	-39.14	-23.18
ROE (%)	-29.41	19.90	-41.46	-50.19	-40.21	-23.27
ROA (%)	-15.24	18.24	-38.01	-45.21	-37.25	-22.39
EBIT Margin (%)	-259.47	37.65	-5,269.10	-101,319.21	-523.39	-282.23
Net Margin (%)	-250.61	35.65	-5,277.55	-101,319.21	-347.63	-297.53
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-85.75	67.75	22.51	-0.99	0.00	7.04
EBIT Growth (%)	-299.55	149.13	-22.26	-46.15	-84.52	-24.61
Net Profit Growth (%)	-542.97	146.44	-22.46	-46.15	-78.20	-29.50
EPS Growth (%)	-1,549.24	1.69	0.09	-0.33	-0.53	-0.19
Book Value Growth (%)	-23.87	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	6.36	-3.41	-7.83	-12.54	-23.34
Price / Book Value	0.84	1.83	1.12	3.61	4.73	5.64
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-13.05	3.03	-0.52	-5.79	-10.06	-20.27
Close Price ($)	10.70	20.36	15.83	39.76	48.02	58.51
High Price ($)	22.55	22.55	73.00	59.96	68.29	75.99
Low Price ($)	9.69	9.12	15.33	27.02	24.38	28.50
Market Cap ($ Cr)	224.44	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.06	0.03	0.04	0.05	0.00
Short term debt to equity ratio	0.01	0.01	0.00	0.00	0.00	0.00
Current Ratio	21.96	15.45	21.45	14.25	17.27	21.23
Quick Ratio	21.96	--	--	13.67	17.32	20.97
Interest Coverage	--	--	--	--	-104,678.00	-14,182.25

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	8.31	2.61	125.52	722.52	4.21	90.53
Asset Turnover	0.06	0.51	0.01	0.00	0.07	0.08
Receivable days	--	8.10	285.36	2,336.63	173.84	167.30
Inventory Days	--	--	4,176.75	2,960.77	250.70	921.67
Payable days	--	795.01	1,493.69	1,969.44	789.75	1,178.32
Cash Conversion Cycle	--	--	2,968.41	3,327.96	-365.21	-89.35

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.